Pay in 4 interest-free payments of $5.22 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
The study did not identify hepatic CYP involvement in ipamorelin's elimination
Presented for research literature review only Guan L et al
Antibodies The following primary antibodies were used: anti-HMOX2 (Cell Signaling Technology, 32790, 1:1,000), anti-HMOX1 (Proteintech, 10701-1-AP, 1:1,000), anti-calnexin (BioLegend, 699402, 1:1,000), anti-MITOL (LSBio (LifeSpan), LS-C164034, 1:1,000), anti-Myc (Cell Signaling Technology, 2276, 1:1,000), anti-Myc (Cell Signaling Technology, 2278, 1:1,000), anti-MFN2 (Santa Cruz Biotechnology, sc-100560, 1:1,000), anti-RMDN3 (Atlas Antibodies, HPA009975, 1:1,000), anti-PDZD8 (Proteintech, 25512-1-AP, 1:1,000), anti--tubulin (Sigma-Aldrich, T9026, 1:5,000), anti-IP3R-I/II/III (Santa Cruz Biotechnology, sc-377518, 1:1,000), anti-VAPB (Proteintech, 66191-1-Ig, 1:1,000), anti-Tom20 (Proteintech, 11802-1-AP, 1:1,000), anti-NDUFA9 (Abcam, ab14713, 1:1,000), anti-NDUFB8 (Abcam, ab110242, 1:1,000), anti-succinate dehydrogenase complex flavoprotein subunit A (SDHA
Biochemistry of B12-cofactors in human metabolism
US$ 27.51
US$ 28.05
US$ 25.63
US$ 21.90
US$ 23.60
